LFBC(SZ:002513)2022-12-07 08:41Group 1: Company Overview - Jiangsu Lanfeng Bio-chemical Co., Ltd. is listed with stock code 002513 and abbreviated as Lanfeng Biochemical [1] Group 2: Investor Relations Activities - The investor relations activity involved specific object research with participation from various investment firms, including Shanghai Zhuque Investment and Guohai Franklin Fund [2] - The meeting took place on December 29, 2015, from 10:00 to 12:00 at Suzhou Suhua Group's main conference room [3] Group 3: Business Development and Projections - In 2016, the company expects to restore normal production in Ningxia Lanfeng, stabilizing the supply of multi-fungicides and related intermediates, leading to no further losses [3] - The company anticipates strong orders for its product, Rhizocone, indicating a positive outlook for its pesticide business [3] - The company plans to enhance its existing pesticide products, reduce excess capacity, and develop new products to improve profitability [4] Group 4: Pharmaceutical Sector Focus - The pharmaceutical sector is prioritized due to its higher added value and better market stability, with plans to support Ark Pharmaceutical's growth and strengthen the research and production of pharmaceutical intermediates [4] - Ark Pharmaceutical is exploring innovative marketing models and patient relationship management to transition from a single product sales model to a comprehensive health service model [4] Group 5: Mergers and Acquisitions Strategy - The company aims to select excellent projects for collaboration and actively seek new profit growth points through its public platform [5] - The projected 20% performance growth in Ark Pharmaceutical's profit forecast is based on the aging population trend and the broad market prospects for its anti-dementia and anti-tumor products [5] - The company plans to maintain its controlling stake through participation in financing activities, ensuring that future acquisitions do not hinder its external development [5][6]